Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018857 · ClinicalTrials.gov registry record
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
A clinical trial of Hepatocellular Carcinoma, sponsored by Federico Aucejo.
- Active
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06018857: Active study of Hepatocellular Carcinoma, sponsored by Federico Aucejo.
NCT06018857 is a study of Hepatocellular Carcinoma that is active but no longer recruiting, run by Federico Aucejo. The registered enrollment target is 1,000 participants, above the 251-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (298% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06018857, a study of Hepatocellular Carcinoma, is active but no longer recruiting, sponsored by Federico Aucejo.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
Conditions Studied
Study Locations (2)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-05-11 |
| Est. Completion | 2028-12 |
What the registry record for NCT06018857 still lists
NCT06018857 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 251-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (298% higher).
The record links to 1 condition, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT06018857 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06018857 about?
NCT06018857 is a clinical study titled "Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation". This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
What is the current status of trial NCT06018857?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2017-05-11. Estimated completion is 2028-12.
What conditions does trial NCT06018857 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma.
Who is sponsoring clinical trial NCT06018857?
This trial is sponsored by Federico Aucejo, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06018857 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06018857's enrollment target sits among peer trials
1,000 9th of 145 higher than 137 of 145 other Hepatocellular Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatocellular Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI